la-jolla-at-sunset-bird

We are dedicated to the discovery, development, and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.

Learn More

Cirrhosis_high_mag

Our current efforts focus on catecholamine-resistant hypotension, conditions characterized by iron overload, serious bacterial infections and rare genetic disorders....

Learn More

scientist working at the laboratory

Our researchers are focused on expanding our pipeline by developing innovative new therapies...

Learn More

Welcome to La Jolla Pharmaceutical Company

We are a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. We have several product candidates in development that we believe have been significantly de-risked. LJPC-501 is our proprietary formulation of angiotensin II, a naturally occurring regulator of blood pressure. LJPC-401 is our novel formulation of hepcidin, an endogenous peptide hormone that controls and regulates iron metabolism. LJPC-30Sa and LJPC-30Sb are La Jolla’s purified derivatives of gentamicin, an FDA-approved antibiotic.

© 2015 La Jolla Pharmaceutical Company